PortfoliosLab logoPortfoliosLab logo
IDNA vs. MDEV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IDNA vs. MDEV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and First Trust Indxx Medical Devices ETF (MDEV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDNA achieves a 14.39% return, which is significantly higher than MDEV's -9.68% return.


IDNA

1D
3.70%
1M
1.49%
YTD
14.39%
6M
11.58%
1Y
45.52%
3Y*
8.39%
5Y*
-7.75%
10Y*

MDEV

1D
2.04%
1M
3.02%
YTD
-9.68%
6M
-10.44%
1Y
-5.82%
3Y*
-2.19%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDNA vs. MDEV - Yearly Performance Comparison


2026 (YTD)20252024202320222021
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
14.39%17.26%-0.72%-7.63%-42.28%-10.15%
MDEV
First Trust Indxx Medical Devices ETF
-9.68%2.00%1.79%7.55%-28.59%4.16%

Correlation

The correlation between IDNA and MDEV is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.56

Correlation (3Y)
Calculated over the trailing 3-year period

0.58

Correlation (All Time)
Calculated using the full available price history since Jun 24, 2021

0.64

The correlation between IDNA and MDEV has been stable across timeframes, ranging from 0.56 to 0.64 - a consistent structural relationship.

IDNA vs. MDEV - Sectors Allocation Comparison


Sectors
IDNA
MDEV

Healthcare

97.8%
100.0%

Industrials

0.4%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IDNA
97.8%
MDEV
100.0%

Industrials

IDNA
0.4%
MDEV

-

Basic Materials

IDNA

-

MDEV

-

Communication Services

IDNA

-

MDEV

-

Consumer Cyclical

IDNA

-

MDEV

-

Consumer Defensive

IDNA

-

MDEV

-

Energy

IDNA

-

MDEV

-

Financial Services

IDNA

-

MDEV

-

Real Estate

IDNA

-

MDEV

-

Technology

IDNA

-

MDEV

-

Utilities

IDNA

-

MDEV

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDNA vs. MDEV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDNA
IDNA Risk / Return Rank: 6262
Overall Rank
IDNA Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 5757
Sortino Ratio Rank
IDNA Omega Ratio Rank: 4848
Omega Ratio Rank
IDNA Calmar Ratio Rank: 8282
Calmar Ratio Rank
IDNA Martin Ratio Rank: 6767
Martin Ratio Rank

MDEV
MDEV Risk / Return Rank: 66
Overall Rank
MDEV Sharpe Ratio Rank: 66
Sharpe Ratio Rank
MDEV Sortino Ratio Rank: 55
Sortino Ratio Rank
MDEV Omega Ratio Rank: 66
Omega Ratio Rank
MDEV Calmar Ratio Rank: 66
Calmar Ratio Rank
MDEV Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDNA vs. MDEV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and First Trust Indxx Medical Devices ETF (MDEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IDNAMDEVDifference
Sharpe ratioReturn per unit of total volatility

+2.21

Sortino ratioReturn per unit of downside risk

+3.07

Omega ratioGain probability vs. loss probability

1.30

0.95

+0.34

Calmar ratioReturn relative to maximum drawdown

4.29

-0.32

+4.61

Martin ratioReturn relative to average drawdown

12.20

-0.80

+13.01

IDNA vs. MDEV - Sharpe Ratio Comparison

The current IDNA Sharpe Ratio is 1.85, which is higher than the MDEV Sharpe Ratio of -0.36. The chart below compares the historical Sharpe Ratios of IDNA and MDEV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IDNAMDEVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.85

-0.36

+2.21

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

-0.30

+0.42

Drawdowns

IDNA vs. MDEV - Drawdown Comparison

The maximum IDNA drawdown since its inception was -68.26%, which is greater than MDEV's maximum drawdown of -42.34%. Use the drawdown chart below to compare losses from any high point for IDNA and MDEV.


Loading charts...

Drawdown Indicators


IDNAMDEVDifference

Max Drawdown

Largest peak-to-trough decline

-68.26%

-42.34%

-25.92%

Max Drawdown (1Y)

Largest decline over 1 year

-10.66%

-18.13%

+7.47%

Max Drawdown (3Y)

Largest decline over 3 years

-29.73%

-22.50%

-7.23%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

Current Drawdown

Current decline from peak

-43.60%

-32.41%

-11.19%

Average Drawdown

Average peak-to-trough decline

-36.25%

-25.66%

-10.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.74%

7.26%

-3.52%

Volatility

IDNA vs. MDEV - Volatility Comparison

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 8.09% compared to First Trust Indxx Medical Devices ETF (MDEV) at 4.98%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than MDEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDNAMDEVDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.09%

4.98%

+3.11%

Volatility (6M)

Calculated over the trailing 6-month period

18.14%

11.61%

+6.53%

Volatility (1Y)

Calculated over the trailing 1-year period

24.71%

16.14%

+8.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.46%

19.00%

+9.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.55%

19.00%

+10.55%

IDNA vs. MDEV - Expense Ratio Comparison

IDNA has a 0.47% expense ratio, which is lower than MDEV's 0.70% expense ratio.


Dividends

IDNA vs. MDEV - Dividend Comparison

IDNA's dividend yield for the trailing twelve months is around 1.03%, while MDEV has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
1.03%1.18%0.98%1.04%0.54%0.70%0.26%0.80%
MDEV
First Trust Indxx Medical Devices ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


IDNA and MDEV have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDNA has higher volatility (8.09%) compared to MDEV (4.98%). In terms of maximum drawdown, IDNA dropped -68.26% vs MDEV's -42.34%.

On 3-year performance, IDNA leads with 8.39% vs -2.19% for MDEV. On fees, IDNA is cheaper at 0.47% per year. On volatility, MDEV has been the lower-risk option at 4.98%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, IDNA has performed better with a 8.39% return vs -2.19%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IDNA is cheaper with a 0.47% expense ratio, compared with 0.70% for MDEV.

IDNA has the higher dividend yield at 1.03%, compared with 0.00% for MDEV.

IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while MDEV tracks Indxx Global Medical Equipment Index. They also come from different issuers: iShares and First Trust. Their fees differ too: 0.47% for IDNA and 0.70% for MDEV.

IDNA currently has the higher Sharpe Ratio (1.85 vs -0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IDNA and MDEV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer